OctoPlus News
Most Popular OctoPlus Story
OctoPlus axes 25% of its staff in streamlining
The Dutch biotech OctoPlus is axing a quarter of its staff, shedding costs while it focuses on advancing its drug delivery technology. OctoPlus is using new controlled-release technology to design Read more...
Latest Headlines
- September 24, 2009
- October 6, 2008
- February 4, 2008
- November 6, 2007
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
